Yes. Ozempic is semaglutide, and it is a GLP-1 receptor agonist: it acts on the receptor for GLP-1, a hormone the gut releases after eating.

No. Ozempic is a GLP-1 receptor agonist, not insulin: it acts on the body's own insulin release rather than replacing insulin. That is why these drugs' labels warn of low blood sugar mainly when they are taken with insulin or a sulfonylurea.

Does Ozempic come in a pill?

Not as Ozempic, which is an injection. The same molecule, semaglutide, is sold as a pill under Wegovy pill and Rybelsus.

What is Ozempic?

What is Ozempic, and how does it work?

Ozempic (semaglutide, diabetes label) is an injection made by Novo Nordisk, whose active ingredient is semaglutide. FDA approved for type 2 diabetes: glycemic control, cardiovascular risk reduction, and kidney outcomes. Weight loss is off-label use. The same molecule as Wegovy, described by its diabetes label: it stimulates insulin and suppresses glucagon, both only when blood glucose is high. Its label reports weight lost in kilograms, which works out to 6.4% mean weight loss; the label itself prints no percentage. It costs $349 a month once titrated, read from its own published page on 2026-09-22 — the maintenance rate rather than the starting dose, because the starting dose is not the dose anyone stays on.

How does Ozempic work? The label's words

Semaglutide is a GLP-1 analog with 94% sequence homology to human GLP-1. Semaglutide acts as a GLP-1 receptor agonist that selectively binds to and activates the GLP-1 receptor, the target for native GLP-1. Semaglutide reduces blood glucose through a mechanism where it stimulates insulin secretion and lowers glucagon secretion, both in a glucose-dependent manner. Thus, when blood glucose is high, insulin secretion is stimulated, and glucagon secretion is inhibited.

Quoted from the mechanism of action section of FDA prescribing information for OZEMPIC (semaglutide) injection, read 2026-08-29. Not paraphrased: how a drug works is the last thing a price site should put in its own words.

What is Ozempic approved for?

Glycemic control in type 2 diabetes
As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Cardiovascular risk reduction in type 2 diabetes
To reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus and established cardiovascular disease.
Kidney outcomes in type 2 diabetes
To reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes mellitus and chronic kidney disease.

Approvals are quoted from the label, because the wording is what a prior authorization is judged against. Which approval a plan cannot exclude — a weight-loss exclusion is written against the use, not the molecule.

How much weight did Ozempic lose in its trial?

6.4% of body weight. No percentage of body weight appears anywhere on the Ozempic label, which has no weight-management section: its three trial sections cover glycemic control, cardiovascular outcomes and kidney outcomes, and all report weight in kilograms. This figure is worked out from the label's own kilograms — 6.4 kg lost from a 100.1 kg mean baseline at week 40 on 2 mg — and is an arithmetic step the label does not take.

One trial, one protocol, one population. Comparing it with another drug's figure compares two separate experiments rather than two drugs — the comparison, and what a point of body weight costs.

It carries a boxed warning — the strongest the FDA issues

In rodents this molecule caused thyroid C-cell tumors at human-relevant doses. Whether it does so in people is unknown, and the label carries that as a boxed warning. It is contraindicated outright with a personal or family history of medullary thyroid carcinoma or MEN 2.

Everything the label lists, including who cannot take it →

How much does Ozempic cost?

$349 a month once titrated, read from its own published page on 2026-09-22. The starting dose is usually cheaper and nobody stays on it, which is why the maintenance figure is the one this site records.

Ozempic price and terms →The cheapest way to get it →

No clinician has reviewed this page. Label and trial statements are quoted from the FDA label or the trial cited beside them. General guidance is marked as such, and every price carries the date it was verified. That is sourcing, not medical review. What we do and do not check · Who checked the price

Ozempic, answered

Is Ozempic a GLP-1?: Yes. Ozempic is semaglutide, and it is a GLP-1 receptor agonist: it acts on the receptor for GLP-1, a hormone the gut releases after eating.
Is Ozempic insulin?: No. Ozempic is a GLP-1 receptor agonist, not insulin: it acts on the body's own insulin release rather than replacing insulin. That is why these drugs' labels warn of low blood sugar mainly when they are taken with insulin or a sulfonylurea.
Does Ozempic come in a pill?: Not as Ozempic, which is an injection. The same molecule, semaglutide, is sold as a pill under Wegovy pill and Rybelsus.

Everything on Ozempic

Last updated 2026-08-29 — the FDA label this page quotes. Read and dated by Alex Seot.